Cardinal Health Deepens Actinium-225 Role As Board Leadership Shifts [Yahoo! Finance]
Cardinal Health, Inc. (CAH)
Last cardinal health, inc. earnings: 2/6 06:55 am
Check Earnings Report
US:NYSE Investor Relations:
ir.cardinalhealth.com/home
Company Research
Source: Yahoo! Finance
Cardinal Health (NYSE:CAH) is expanding production capacity for the medical radioisotope Actinium-225 to support targeted alpha therapies for cancer treatment worldwide. The company is positioning this capacity for both clinical trials and potential commercial manufacturing in global markets. Cardinal Health announced that Patricia A. Hemingway Hall has been appointed Chair of the Board, following a period of company transformation. The leadership change and Actinium-225 expansion were disclosed as material company developments within the past week. For investors watching healthcare services and pharmaceutical distribution, Cardinal Health sits at the intersection of drug supply chains, specialty therapies, and nuclear medicine. Targeted alpha therapies using Actinium-225 are part of a broader push in oncology toward treatments designed to focus radiation on cancer cells while limiting exposure to healthy tissue. As more drug developers explore these approaches, suppliers of
Show less
Read more
Impact Snapshot
Event Time:
CAH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAH alerts
High impacting Cardinal Health, Inc. news events
Weekly update
A roundup of the hottest topics
CAH
News
- Insiders At Cardinal Health Sold US$53m In Stock, Alluding To Potential Weakness [Yahoo! Finance]Yahoo! Finance
- Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies [Yahoo! Finance]Yahoo! Finance
- Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapiesPR Newswire
- Jim Cramer on Cardinal Health: “I Want You to Buy It and Buy It, Get This, Aggressively” [Yahoo! Finance]Yahoo! Finance
- 3 Dividend Aristocrat Stocks Up 200% That Nobody Is Talking About [Yahoo! Finance]Yahoo! Finance
CAH
Earnings
- 2/5/26 - Beat
CAH
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/23/26 - Form 8-K
- 3/5/26 - Form 8-K
- CAH's page on the SEC website